MAC30 knockdown involved in the activation of the Hippo signaling pathway in breast cancer cells

References

Bartz, F., Kern, L., Erz, D., Zhu, M., Gilbert, D., Meinhof, T., Wirkner, U., Erfle, H., Muckenthaler, M., Pepperkok, R., et al. (2009). Identification of cholesterol-regulating genes by targeted RNAi screening. Cell Metab. 10, 63–75.10.1016/j.cmet.2009.05.009Search in Google Scholar PubMed

Gyorffy, B., Lanczky, A., and Szallasi, Z. (2012). Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr. Relat. Cancer 19, 197–208.10.1530/ERC-11-0329Search in Google Scholar PubMed

Halder, G. and Johnson, R.L. (2011). Hippo signaling: growth control and beyond. Development 138, 9–22.10.1242/dev.045500Search in Google Scholar PubMed PubMed Central

Han, K.Y., Gu, X., Wang, H.R., Liu, D., Lv, F.Z., and Li, J.N. (2013). Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer. Tumour Biol. 34, 821–825.10.1007/s13277-012-0612-zSearch in Google Scholar PubMed

Li, K., Xia, L., Liu, N.F., Nicoli, F., Constantinides, J., D’Ambrosia, C., Lazzeri, D., Tremp, M., Zhang, J.F., and Zhang, Y.X. (2017). Far infrared ray (FIR) therapy: an effective and oncological safe treatment modality for breast cancer related lymphedema. J. Photochem. Photobiol. B 172, 95–101.10.1016/j.jphotobiol.2017.05.011Search in Google Scholar PubMed

Maugeri-Saccà, M., Barba, M., Pizzuti, L., Vici, P., Di Lauro, L., Dattilo, R., Vitale, I., Bartucci, M., Mottolese, M., and De Maria, R. (2015). The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. Expert Rev. Mol. Med. 17, e14.10.1017/erm.2015.12Search in Google Scholar PubMed

Montagna, E., Vingiani, A., Maisonneuve, P., Cancello, G., Contaldo, F., Pruneri, G., and Colleoni, M. (2017). Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy. Breast 34, 83–88.10.1016/j.breast.2017.05.009Search in Google Scholar PubMed

Moparthi, S.B., Arbman, G., Wallin, A., Kayed, H., Kleeff, J., Zentgraf, H., and Sun, X.F. (2007). Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int. J. Oncol. 30, 91–95.10.3892/ijo.30.1.91Search in Google Scholar

Murphy, M., Pykett, M.J., Harnish, P., Zang, K.D., and George, D.L. (1993). Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ. 4, 715–722.Search in Google Scholar

Park, H.W. and Guan, K.L. (2013). Regulation of the Hippo pathway and implications for anticancer drug development. Trends Pharmacol. Sci. 34, 581–589.10.1016/j.tips.2013.08.006Search in Google Scholar PubMed PubMed Central

Siegel, R.L., Miller, K.D., and Jemal, A. (2016). Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30.10.3322/caac.21332Search in Google Scholar PubMed

Song, G.Q. and Zhao, Y. (2015). Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition. Oncol. Rep. 33, 669–674.10.3892/or.2014.3619Search in Google Scholar PubMed

Xia, P. and Xu, X.Y. (2016). Prognostic significance of CD44 in human colon cancer and gastric cancer: evidence from bioinformatic analyses. Oncotarget 7, 45538–45546.10.18632/oncotarget.9998Search in Google Scholar PubMed PubMed Central

Xiao, M., Li, H., Yang, S., Huang, Y., Jia, S., Wang, H., Wang, J., and Li, Z. (2013). Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer. J. Surg. Oncol. 107, 456–462.10.1002/jso.23269Search in Google Scholar PubMed

Xie, S., Shen, C., Tan, M., Li, M., Song, X., and Wang, C. (2017). Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer. Oncotarget 8, 27216–27239.10.1183/1393003.congress-2017.PA4198Search in Google Scholar

Xu, X.Y., Zhang, L.J., Yu, Y.Q., Zhang, X.T., Huang, W.J., Nie, X.C., and Song, G.Q. (2014). Down-regulated MAC30 expression inhibits proliferation and mobility of human gastric cancer cells. Cell Physiol. Biochem. 33, 1359–1368.10.1159/000358703Search in Google Scholar PubMed

Yan, B.Y., Wang, D.W., Zhu, Z.L., Yang, Y.H., Wang, M.W., Cui, D.S., Zhang, H., and Sun, X.F. (2010). Overexpression of MAC30 in the cytoplasm of oral squamous cell carcinoma predicts nodal metastasis and poor differentiation. Chemotherapy 56, 424–428.10.1159/000317582Search in Google Scholar PubMed

Yeung, B., Yu, J., and Yang, X. (2016). Roles of the Hippo pathway in lung development and tumorigenesis. Int. J. Cancer 138, 533–539.10.1002/ijc.29457Search in Google Scholar PubMed

Yu, F.X. and Guan, K.L. (2013). The Hippo pathway: regulators and regulations. Genes Dev. 27, 355–371.10.1101/gad.210773.112Search in Google Scholar PubMed PubMed Central

Zhang, Z.Y., Zhao, Z.R., Adell, G., Jarlsfelt, I., Cui, Y.X., Kayed, H., Kleeff, J., Wang, M.W., and Sun, X.F. (2006). Expression of MAC30 in rectal cancers with or without preoperative radiotherapy. Oncology 71, 259–265.10.1159/000106449Search in Google Scholar PubMed

Zhao, Z.R., Zhang, L.J., He, X.Q., Zhang, Z.Y., Zhang, F., Li, F., Pei, Y.B., Hu, Y.M., Wang, M.W., and Sun, X.F. (2011). Significance of mRNA and protein expression of MAC30 in progression of colorectal cancer. Chemotherapy 57, 394–401.10.1159/000331716Search in Google Scholar PubMed